4.5 Review

Tiny Drosophila makes giant strides in cancer research

Journal

CANCER SCIENCE
Volume 112, Issue 2, Pages 505-514

Publisher

WILEY
DOI: 10.1111/cas.14747

Keywords

anti‐ cancer drug; cancer; Drosophila; genetics; whole‐ body platform

Categories

Funding

  1. Joint Usage/Research Center for Genetic Medicine, Hokkaido University
  2. Photo-excitonix Project in Hokkaido University
  3. MEXT/JSPS KAKENHI [19H05412, 19K22478, 20H03524, 20K07558]
  4. AMED [JP20ck0106548, JP20cm0106273]
  5. AMED (Translational Research program)
  6. AMED (Strategic PRomotion for practical application of INnovative medical Technology (TR-SPRINT))
  7. MSD Life Science Foundation
  8. SGH Foundation
  9. Foundation for Promotion of Cancer Research in Japan
  10. Project Mirai Cancer Research Grants
  11. Ichiro Kanehara Foundation
  12. Princess Takamatsu Cancer Research Fund
  13. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  14. Suhara Memorial Foundation
  15. Tokyo Biochemical Research Foundation
  16. Japan Foundation for Applied Enzymology
  17. Takeda Science Foundation
  18. Suzuken Memorial Foundation
  19. Akiyama Life Science Foundation
  20. All Japan Coffee Association
  21. Pharmacological Research Foundation, Tokyo
  22. Grants-in-Aid for Scientific Research [19K22478, 19H05412, 20K07558, 20H03524] Funding Source: KAKEN

Ask authors/readers for more resources

The fruit fly Drosophila has played a crucial role in advancing cancer research by providing insights into fundamental mechanisms of cancer development, such as loss of cell polarity. In recent years, scalable Drosophila platforms have proved useful in developing effective anti-cancer regimens for both mammalian models and patients.
Cancer burden has been increasing worldwide, making cancer the second leading cause of death in the world. Over the past decades, various experimental models have provided important insights into the nature of cancer. Among them, the fruit fly Drosophila as a whole-animal toolkit has made a decisive contribution to our understanding of fundamental mechanisms of cancer development including loss of cell polarity. In recent years, scalable Drosophila platforms have proven useful also in developing anti-cancer regimens that are effective not only in mammalian models but also in patients. Here, we review studies using Drosophila as a tool to advance cancer study by complementing other traditional research systems.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available